Literature DB >> 9668273

Drug-induced autoimmune myasthenia gravis.

A S Penn1, B W Low, I A Jaffe, L Luo, J J Jacques.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9668273     DOI： 10.1111/j.1749-6632.1998.tb10961.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN： 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  5 in total

1.  Neuromuscular junction toxicity with tandutinib induces a myasthenic-like syndrome.

Authors:  T J Lehky; F M Iwamoto; T N Kreisl; M K Floeter; H A Fine
Journal:  Neurology       Date:  2011-01-18       Impact factor: 9.910

Review 2.  Immunotoxicology: role in the safety assessment of drugs.

Authors:  Jacques Descotes
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

Review 3.  Update on myasthenia gravis.

Authors:  B R Thanvi; T C N Lo
Journal:  Postgrad Med J       Date:  2004-12       Impact factor: 2.401

4.  Statins may aggravate myasthenia gravis.

Authors:  Shin J Oh; Rohit Dhall; Angela Young; Marla B Morgan; Liang Lu; Gwendolyn C Claussen
Journal:  Muscle Nerve       Date:  2008-09       Impact factor: 3.217

Review 5.  Pathophysiological basis in the management of myasthenia gravis: a mini review.

Authors:  Aiswarya Binu; Sarath S Kumar; Uma Devi Padma; Krishnadas Madhu
Journal:  Inflammopharmacology       Date:  2022-01-21       Impact factor: 4.473
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.